Moderna vs UnitedHealth Group: Business Model & Financial Comparison 2026
Moderna · Healthcare / Biotechnology·UnitedHealth Group · Healthcare / Healthcare Plans
Financial Comparison
| Metric | MRNAModerna | UNHUnitedHealth Group |
|---|---|---|
| Market Cap | $21.17B | $255.57B |
| Revenue (TTM) | $1.94B | $447.57B |
| Revenue Growth | -29.8% | 12.3% |
| Gross Margin | -105.8% | 18.5% |
| Operating Margin | -126.4% | 0.3% |
| Net Margin | -145.2% | 2.7% |
| Return on Equity | -28.9% | 12.5% |
| P/E (Trailing) | N/A | 21.3x |
| P/E (Forward) | -11.7x | 14.1x |
| Free Cash Flow | $-1.33B | $13.86B |
| Cash | $5.80B | $28.12B |
| Total Debt | $1.30B | $83.00B |
Data sourced from Yahoo Finance. Green highlights indicate better performance for that metric. Use the interactive tool for real-time data.
Business Model Comparison
Moderna
Moderna, Inc. stands as a leading company in Healthcare. Generating $1.94 billion in annual revenue (growing -29.8% year-over-year) and carrying a market capitalization of $21.26 billion, the company has cemented its position as a foundational player in the global Biotechnology landscape. Under the leadership of its leadership team, Moderna, Inc. continues to execute on a multi-year strategic vision that balances growth investment with shareholde…
Full Moderna analysis →UnitedHealth Group
UnitedHealth Group Incorporated stands as a leading company in Healthcare. Generating $447.57 billion in annual revenue (growing 12.3% year-over-year) and carrying a market capitalization of $261.58 billion, the company has cemented its position as a foundational player in the global Healthcare Plans landscape. Under the leadership of its leadership team, UnitedHealth Group Incorporated continues to execute on a multi-year strategic vision that b…
Full UnitedHealth Group analysis →SWOT Analysis Comparison
Strengths
Moderna
- Moderna, Inc. holds an established position in the Biotechnology sector, with a track record of serving customers and generating value across its core business activities.
- The company's deep expertise in Biotechnology — developed over years of operation — provides meaningful barriers to entry and customer relationship advantages that newer competitors must overcome.
UnitedHealth Group
- With a market capitalization of $261.58B, UnitedHealth Group Incorporated is one of the largest companies in its sector, providing the scale advantages of brand recognition, supplier leverage, and cap
- Revenue grew 12.3% year-over-year to $447.57B, indicating strong demand for UnitedHealth Group Incorporated's products and services and outperformance relative to many industry peers.
- UnitedHealth Group Incorporated generated $13.86B in free cash flow, providing financial flexibility to invest in growth initiatives, return capital to shareholders, or strengthen the balance sheet.
Weaknesses
Moderna
- Year-over-year revenue declined 29.8%, raising questions about demand for Moderna, Inc.'s core offerings and requiring management to articulate a credible recovery path.
UnitedHealth Group
- UnitedHealth Group Incorporated's debt-to-equity ratio of 81.6 indicates meaningful financial leverage. Total debt stands at $83.00B against $28.12B in cash and equivalents.
- A net profit margin of 2.7% leaves limited buffer against revenue fluctuations or cost increases. Any significant market downturn could quickly pressure profitability.
- With 390,000 employees globally, UnitedHealth Group Incorporated faces inherent challenges in agility, decision-making speed, and maintaining a consistent culture across geographies — advantages that
Opportunities
Moderna
- Moderna, Inc. operates in the Biotechnology segment of the broader Healthcare sector, which represents a $12 trillion global healthcare market by 2030. Even modest share gains in this environment tran
- Emerging markets — particularly India (1.4B people, rapidly growing middle class), Southeast Asia (700M people), and Sub-Saharan Africa — represent significant untapped addressable markets for Moderna
- With $5.80B in cash and strong free cash flow generation, Moderna, Inc. is well-positioned to pursue strategic acquisitions that expand its capabilities, customer base, or geographic reach.
UnitedHealth Group
- UnitedHealth Group Incorporated operates in the Healthcare Plans segment of the broader Healthcare sector, which represents a $12 trillion global healthcare market by 2030. Even modest share gains in
- Emerging markets — particularly India (1.4B people, rapidly growing middle class), Southeast Asia (700M people), and Sub-Saharan Africa — represent significant untapped addressable markets for UnitedH
- With $28.12B in cash and strong free cash flow generation, UnitedHealth Group Incorporated is well-positioned to pursue strategic acquisitions that expand its capabilities, customer base, or geographi
Threats
Moderna
- Global economic slowdowns, inflation, or rising interest rates can reduce consumer and enterprise spending. Moderna, Inc.'s revenue is not fully insulated from macroeconomic cycles, and a recession sc
- Increasing government regulation — particularly data privacy laws (GDPR, CCPA), antitrust enforcement, and trade restrictions — poses compliance costs and potential restrictions on Moderna, Inc.'s bus
- Competition for skilled technology, engineering, and management talent remains intense. High employee turnover or inability to attract top talent could slow innovation and execution — particularly cri
UnitedHealth Group
- Global economic slowdowns, inflation, or rising interest rates can reduce consumer and enterprise spending. UnitedHealth Group Incorporated's revenue is not fully insulated from macroeconomic cycles,
- Increasing government regulation — particularly data privacy laws (GDPR, CCPA), antitrust enforcement, and trade restrictions — poses compliance costs and potential restrictions on UnitedHealth Group
- Competition for skilled technology, engineering, and management talent remains intense. High employee turnover or inability to attract top talent could slow innovation and execution — particularly cri
Compare any 2–4 companies with live data
The interactive comparison tool lets you select any companies, see real-time metrics, and export a side-by-side report.
Open Comparison ToolModerna vs UnitedHealth Group: FAQ
- Is Moderna bigger than UnitedHealth Group?
- By market capitalization, UnitedHealth Group is larger at $255.57B vs Moderna's $21.17B.
- Which has better profit margins — Moderna or UnitedHealth Group?
- UnitedHealth Group has higher net profit margins (2.7%) compared to Moderna (-145.2%). Gross and operating margins are compared in the table above.
- What sectors do Moderna and UnitedHealth Group operate in?
- Moderna operates in the Healthcare sector (Biotechnology). UnitedHealth Group operates in the Healthcare sector (Healthcare Plans).
- How does Moderna's revenue compare to UnitedHealth Group's?
- Moderna generates $1.94B in annual revenue (TTM) while UnitedHealth Group generates $447.57B. UnitedHealth Group is the larger company by revenue as of 2026.